#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Perspectives in Surgery / 2020 - 10

Postoperative chylothorax − review

Czech version

Authors: M. Szkorupa
Authors‘ workplace: I. chirurgická klinika Fakultní nemocnice Olomouc
Published in: Rozhl. Chir., 2020, roč. 99, č. 10, s. 427-437.
Category: Review

Overview

The spectrum of causes of chylothorax is wide, including an injury to the thoracic duct in various thoracosurgical procedures, especially in esopha­geal, lung and heart surgery. Late diagnosis or inadequate treatment of chylothorax still has a high rate of morbidity and mortality. This is mainly related to high losses of chyle which is rich in minerals, plasma proteins, fats and lymphocytes. The most serious effects are mineral breakdown, malnutrition and immunodeficiency. Early diagnosis and adequate therapy are essential. The strategy is based on the type of primary operation, the volume of chyle secretion and its duration.

The authors present an overview of the issue of chylothorax from its etiology of origin to its anatomy, physiology, pathophysiology, symptomatology, diagnosis and therapy.

Keywords:

chylothorax – radiology – ligation − laparoscopy

Sources
  1. Young S, Dalgleish S, Eccleston A, et al. Severe congenital chylothorax treated with octreotide. Journal of Perinatology 2004;24(3):200−202.
  2. Doerr CH, Allen MS, Nichols III FC, et al. Etiology of chylothorax in 203 patients. In Mayo Clinic Proceedings, Elsevier 2005;80(7):867–870). doi: 10.4065/80.7.867.
  3. Cerfolio RJ, Allen MS, Deschamps C, et al. Postoperative chylothorax. The Journal of Thoracic and Cardiovascular Surgery 1996;112(5):1361−1366. doi: 10.1016/S0022-5223(96)70152-6.
  4. Seitelman E, Arellano JJ, Takabe K, et al. Chylothorax after blunt trauma. Journal of Thoracic Disease 2012;4(3):327. doi: 10.3978/2072-1439.2011.09.03.
  5. Robinson CLN. The management of chylothorax. The Annals of Thoracic Surgery 1985;39(1):90–95. doi: 10.1016/S0003-4975(10)62531-3.
  6. Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. European Journal of Cardio-Thoracic Surgery 2007;32(2):362−369. doi: 10.1016/j.ejcts.2007.04.024.
  7. Chen E, Itkin M. Thoracic duct embolization for chylous leaks. In Seminars in interventional radiology © Thieme Medi­cal Publishers 2011;28(1):063−074. doi: 10.1055/s-0031-1273941.
  8. Heffner JE. Etiology, clinical presentation, and diagnosis of chylothorax. 2015. Available at: www.uptodate.com/contents/etiology-clinicalpresentation-and-diagnosis-of-chylothorax
  9. Žáčková P, Vašáková M. Chylothorax a pseudochylothorax: diferenciální diagnostika a současné terapeutické možnosti. Prakt Lék. 2008;88.6:352−358.
  10. Chinnock BF. Chylothorax: case report and review of the literature. The Journal of Emergency Medicine 2003;24(3):259−262. doi: 10.1016/S0736-4679(02)00751-5.
  11. Bessone LN, Ferguson TB, Burford TH. Chylothorax. The Annals of Thoracic Surgery 1971;12(5):527−550. doi: 10.1016/S0003-4975(10)65800-6.
  12. Schild HH, Strassburg CP, Welz A, et al. Treatment options in patients with chylothorax. Deutsches Ärzteblatt International 2013;110(48):819. doi: 10.3238/arztebl.2013.0819.
  13. Maldonado F, Hawkins FJ, Daniels CE, et al. Pleural fluid characteristics of chylothorax. In Mayo Clinic Proceedings Elsevier 2009;84(2):129−133. doi: 10.4065/84.2.129.
  14. McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respiratory Medicine 2010;104(1):1−8. doi: 10.1016/j.rmed.2009.08.010.
  15. Staats BA, Ellefson RD, Budahn LL, et al. The lipoprotein profile of chylous and nonchylous pleural effusions. In Mayo Clinic Proceedings 1980;55(11):700−704.
  16. Hillerdal G. Chyliform (cholesterol) pleural effusion. Chest 1985;88(3):426−428. doi: 10.1378/chest.88.3.426.
  17. Lee EW, Shin JH, Ko HK, et al. Lymphangiography to treat postoperative lymphatic leakage: a technical review. Korean Journal of Radiology 2014;15(6):724−732. doi: 10.3348/kjr.2014.15.6.724.
  18. Lafont JE, Rau W, Krompiec C, et al. Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiologica 2011 (Stockholm, Sweden: 1987). doi: 10.1258/ar.2010.090356.
  19. Deso S, Ludwig B, Kabutey NK, et al. Lymphangiography in the diagnosis and localization of various chyle leaks. Cardiovascular and Interventional Radiology 2012;35(1):117−126. doi: 10.1007/s00270-010-0066-x.
  20. Guermazi A, Brice P, Hennequin C, et al. Lymphography: an old technique retains its usefulness. Radiographics 2003;23(6):1541−1558. doi: 10.1148/rg.236035704.
  21. Sugiura K, Tanabe Y, Ogawa T, et al. Locali­zation of chyle leakage site in postoperative chylothorax by oral administration of I-123 BMIPP. Annals of Nuclear Medicine 2005;19(7):597−601. doi: 10.1007/BF02985053.
  22. Momose M, Kawakami S, Koizumi T, et al. Lymphoscintigraphy using technetium-99m HSA-DTPA with SPECT/CT in chylothorax after childbirth. Radiation Medicine 2008;26(8):508−511. doi: 10.1007/s11604-008-0265-4.
  23. Ohtsuka A, Inoue Y, Asano Y, et al. Lymphoscintigraphy using dynamic imaging and SPECT/CT in chylothorax. Open Journal of Medical Imaging 2013;3(3). doi: 10.4236/ojmi.2013.33013.
  24. Chang YC, Yen YT, Chang MC, et al. Localization of thoracic duct using heavily T2W MRI for intractable post-esophagectomy chylothorax—a case report. Journal of Thoracic Disease 2017;9(2): E109. doi: 10.21037/jtd.2017.02.37.
  25. Shah RD, Luketich, JD, Schuchert MJ, et al. Postesophagectomy chylothorax: incidence, risk factors, and outcomes. The Annals of Thoracic Surgery 2010;93(3):897−904. doi: 10.1016/j.athoracsur.2011.10.060.
  26. Mery CM, Moffett BS, Khan MS, et al. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. The Journal of Thoracic and Cardiovascular Surgery 2014;147(2):678−686. doi: 10.1016/j.jtcvs.2013.09.068.
  27. Kilic D, Sahin E, Gulcan O, et al. Octreotide for treating chylothorax after cardiac surgery. Texas Heart Institute Journal 2005;32(3):437.
  28. Uchida S, Suzuki K, Hattori A, et al. Surgical intervention strategy for postoperative chylothorax after lung resection. Surgery Today 2016;46(2):197−202. doi: 10.1007/s00595-015-1183-6.
  29. Shimizu K, Yoshida J, Nishimura M, et al. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2002;124(3):499−502. doi: 10.1067/mtc.2002.124386.
  30. Buckley JR, Graham EM, Gaies M, et al. Cli­nical epidemiology and centre variation in chylothorax rates after cardiac surgery in children: a report from the pediatric cardiac critical care consortium. Cardio­logy in the Young 2017;27(9):1678−1685. doi: 10.1017/S104795111700097X.
  31. Miao L, Zhang Y, Hu H, et al. Incidence and management of chylothorax after esophagectomy. Thoracic Cancer 2015;6(3):354−358. doi: 10.1111/1759-7714.12240.
  32. Terzi A, Furlan G, Magnanelli G, et al. Chylothorax after pleuro-pulmonary surgery: a rare but unavoidable complication. The Thoracic and Cardiovascular Surgeon 1994;42(02):81−84. doi: 10.1055/s-2007-1016462.
  33. Stolz A, Pafko P. Komplikace v plicní chirurgii. Praha, Grada Publishing 2010. 
  34. Valentine VG,  Raffin TA. The management of chylothorax. Chest 1992;102(2):586−591. doi: 10.1378/chest.102.2.586.
  35. Pillay TG, Singh B. A review of traumatic chylothorax. Injury 2016;47(3):545−550. doi: 10.1016/j.injury.2015.12.015.
  36. Ulíbarri J, Sanz Y, Fuentes C, et al. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. The Lancet 1990;336(8709):258. doi: 10.1016/0140-6736(90)91793-a.
  37. Collard JM, Laterre PF, Boemer F, et al. Conservative treatment of postsurgical lymphatic leaks with somatostatin-14. Chest 2000;117(3):902-905. doi: 10.1378/chest.117.3.902.
  38. Du Rieu MC, Mabrut JY. Management of postoperative chylothorax. Journal of Visceral Surgery 2011;148(5):e346−e352. doi: 10.1016/j.jviscsurg.2011.09.006.
  39. Lim KA, Kim SH, Huh J, et al. Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease. Journal of Korean Medical Science 2005;20(6):947–951. doi: 10.3346/jkms.2005.20.6.947.
  40. Bello SO, Rahamim J. High-dose intravenous octreotide is safe and may be superior to surgery in managing severe postesophagectomy chylothorax in high-risk patients. The Annals of Thoracic Surgery 2015;100(1):297−299. doi: 10.1016/j.athoracsur.2014.08.058.
  41. Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. Journal of Vascular and Interventional Radiology 1998;9(5):727−734. doi: 10.1016/s1051-0443(98)70382-3.
  42. Itkin M, Kucharczuk JC, Kwak A, et al. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. The Journal of Thoracic and Cardiovascular Surgery 2010;139(3):584−590. doi: 10.1016/j.jtcvs.2009.11.025.
  43. Higgins MC, Park AW, Angle JF. Chylothorax: percutaneous embolization of the thoracic duct. Operative Techniques in Thoracic and Cardiovascular Surgery 2015;20(4):402−412. doi: 10.1053/j.optechstcvs.2016.04.002.
  44. Dugue L, Sauvanet A, Farges O, et al. Output of chyle as an indicator of treatment for chylothorax complicating oesophagectomy. British Journal of Surgery 1998;85(8):1147−1149. doi: 10.1046/j.1365-2168.1998.00819.x.
  45. Merigliano S, Molena D, Ruol A, et al. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. The Journal of Thoracic and Cardiovascular Surgery 2000;119(3):453–457. doi: 10.1016/s0022-5223(00)70123-1.
  46. Hou X, Fu JH, Wang X, et al. Prophylactic thoracic duct ligation has unfavorable impact on overall survival in patients with resectable oesophageal cancer. European Journal of Surgical Oncology (EJSO) 2014;40(12):1756−1762. doi: 10.1016/j.ejso.2014.05.002.
  47. Choh CT, Khan OA, Rychlik IJ, et al. Does ligation of the thoracic duct during oeso­phagectomy reduce the incidence of post-operative chylothorax? International Journal of Surgery 2012;10(4):203−205. doi: 10.1016/j.ijsu.2012.03.011.
  48. Paul S, Altorki NK, Port JL, et al. Surgical management of chylothorax. The Thoracic and Cardiovascular Surgeon 2009;57(04):226−228. doi: 10.1055/s-0029-1185457.
  49. Hayden JD, Sue-Ling HM, Sarela AI, et al. Minimally invasive management of chylous fistula after esophagectomy. Diseases of the Esophagus 2007;20(3):251−255. doi: 10.1111/j.1442-2050.2007.00644.x.
  50. Ahmed SU, Sancheti MS, Pickens A. Thoracoscopic thoracic duct ligation. Ope­rative Techniques in Thoracic and Cardio­vascular Surgery 2012;17(4):292−301. doi: 10.1053/j.optechstcvs.2012.11.003.
  51. Vassallo BC, Cavadas D, Beveraggi E, et al. Treatment of postoperative chylothorax through laparoscopic thoracic duct ligation. European Journal of Cardio-Thoracic Surgery 2002;21(3):556–557. doi: 10.1016/s1010-7940(01)01137-x.
  52. Seeliger B, Alesina PF, Walz MK. Posterior retroperitoneoscopic thoracic duct ligation: a novel surgical approach. Surgical Endoscopy 2018;32(8):3732−3737. doi: 10.1007/s00464-018-6262-5.
  53. Takuwa T, Yoshida J, Ono S, et al. Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2013;146(3):571−574. doi: 10.1016/j.jtcvs.2013.04.015.
  54. Jianjun Q, Song Z, Yin L, et al. Treatment of chylothorax with elemene. The Thoracic and Cardiovascular Surgeon 2008;56(02):103−105. doi: 10.1055/s-2007-965708.
  55. Engum SA, Rescorla FJ, West KW, et al. The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants. Journal of Pediatric Surgery 1999;34(2):286−290. doi: 10.1016/s0022-3468(99)90192-6.
  56. Wolff AB, Silen ML, Kokoska ER, et al. Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children. The Annals of Thoracic Surgery 1999;68(3):1053−1057. doi: 10.1016/s0003-4975(99)00880-2.
  57. Tutor JD. Chylothorax in infants and children. Pediatrics 2014;133(4):722−733. doi: 10.1542/peds.2013-2072.
Labels
Surgery Orthopaedics Trauma surgery
Role of extracorporeal life support in thoracic surgery
Treatment of anastomotic leak after Ivor Lewis esophagectomy
Malignancy after lung transplantation
Hyperthermic intraoperative intrapleural chemotherapy and surgical cytoreduction as part of multimodal treatment of malignant pleural mesothelioma – case report M. Szkorupa1, D. Klos1, J. Chudacek1, J. Hanuliak1, M. Stasek1, O. Fischer2, R. Lemstrova3
Pulmonary metastases in pseudomyxoma peritonei – case report and review of the literature
Pulmonary arteriovenous malformation managed by VATS lobectomy
Minimalizace a maximalizace v hrudní chirurgii
Article was published in

Perspectives in Surgery

Issue 10
2020 Issue 10
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#